DANTZKER DAVID 4
4 · SURMODICS INC · Filed Nov 15, 2022
Insider Transaction Report
Form 4
SURMODICS INCSRDX
DANTZKER DAVID
Other
Transactions
- Sale
Common Stock
2022-11-14$33.00/sh−2,773$91,507→ 34,178 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-14−4,366→ 0 totalExercise: $20.18Exp: 2022-12-18→ Common Stock (4,366 underlying) - Exercise/Conversion
Common Stock
2022-11-14$20.18/sh+4,366$88,106→ 36,951 total
Footnotes (3)
- [F1]Reflects the weighted average price of 2,773 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 14, 2022 with sale prices ranging from $32.9021 to $33.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The amount beneficially owned includes 11,985 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- [F3]Fully vested.